(2021/08/30)
(2018/04/03)
p. 507 - 509
(2013/12/04)p. 14 - 19
(2013/08/24)p. 261 - 262
(2013/06/05)p. 4365 - 4370
(2013/01/14)p. 10696 - 10699
(2011/09/15)(2011/11/13)
p. 3380 - 3383
(2010/11/04)p. 373 - 393
(2010/11/18)(2010/06/15)
p. 2112 - 2116
(2010/02/28)(2009/09/07)
(2010/11/28)
(2010/11/29)
p. 1815 - 1822
(2007/10/03)p. 335 - 337
(2007/10/03)(2010/11/08)
(2010/02/12)
(2010/02/12)
(2010/02/12)
(2010/02/12)
(2010/02/12)
(2010/02/12)
(2008/06/13)
(2008/06/13)
p. 1871 - 1877
(2007/10/03)p. 608 - 614
(2007/10/03)(2008/06/13)
p. 3673 - 3683
(2007/10/03)(2008/06/13)
p. 1895 - 1911
(2007/10/02)quinuclidin-3-yl butyrate b
4-nitrobenzoic acid (S)-(1-aza-bicyclo[2.2.2]oct-3-yl)ester fumarate
(3S,4S)-3-(tert-Butyl-dimethyl-silanyloxy)-4-(2-methanesulfonyloxy-ethyl)-piperidine-1-carboxylic acid benzyl ester
(3S,4S)-3-Hydroxy-4-(2-methanesulfonyloxy-ethyl)-piperidine-1-carboxylic acid benzyl ester
Methanesulfonic acid (2S,3S,6S)-3-dimethylcarbamoylmethyl-6-methoxy-3,6-dihydro-2H-pyran-2-ylmethyl ester
(S)-quinuclidin-3-yl benzoate
[(3S)-1-azabicyclo[2.2.2]octan-3-yl] N-[2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl]carbamate
(S)-quinuclidin-3-yl (2-(4’-(2-methoxyethoxy)-[1,1‘-biphenyl]-4-yl)propan-2-yl)carbamate
(S)-quinuclidin-3-yl 2-(4-(4-fluorophenyl)thiazol-2-yl)propan-2-ylcarbamate